PTGS2 and cholangiocarcinoma: Yeh et al. reported the development of m-[18F]fluorofenbufen ester boronopinacol (m-[18F]FFBPin) for boron neutron capture therapy (BNCT) of aggressive cholangiocarcinoma (CCA) that overexpresses COX-2 enzyme [85].